Accueil
Détail de l'auteur
Auteur B. KILMER |
Documents disponibles écrits par cet auteur (34)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
BACKGROUND: Marijuana contains multiple cannabinoids. Most attention is given to delta-9-tetrahydrocannabinol (THC) which produces euphoria and in some cases anxiety and panic reactions. Research suggests that another cannabinoid, cannabidiol (C[...]Rapport
Article : Périodique
J. P. CAULKINS ; B. PARDO ; B. KILMER |Background: Drug use is often measured in terms of prevalence, meaning the number of people who used any amount in the last month or year, but measuring the quantity consumed is critical for making informed regulatory decisions and estimating th[...]Livre
J. P. CAULKINS ; A. HAWKEN ; B. KILMER ; M. A. R. KLEIMAN | Oxford - New York : Oxford University Press | What everyone needs to know | 2012Should marijuana be legalized? The latest Gallup poll reports that exactly half of Americans say "yes"; opinion couldn't be more evenly divided. Marijuana is forbidden by international treaties and by national and local laws across the globe. B[...]Rapport
J. P. CAULKINS ; K. FURLONG ; B. McCOMAS ; M. NOGUEIRA DOMINGUES ; A. SIDDIQUE ; B. KILMER | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2022This chapter explores two methods of bringing together the complementary strengths of general population surveys (GPS) and web surveys to develop improved estimates of overall quantities of drugs consumed — namely, raking and regression. Raking [...]Rapport
B. KILMER ; K. KRUITHOF ; M. PARDAL ; J. P. CAULKINS ; J. RUBIN | Santa Monica, CA : Rand Corporation | Research Reports | 2013In July 2013, the Research and Documentation Centre (WODC) of the Netherlands Ministry of Security and Justice asked RAND Europe to provide a multinational overview of cannabis production regimes, with a special focus on identifying and describi[...]Rapport
As more jurisdictions contemplate and pass laws to legalise cannabis for medical and non-medical purposes, the discussions about cannabis policy will likely become more intense in the EU. Member States can learn from these experiences and decide[...]Rapport
J. P. CAULKINS ; B. KILMER ; M. A. R. KLEIMAN ; R. J. MACCOUN ; G. MIDGETTE ; P. OGLESBY ; R. L. PACULA ; P. H. REUTER | Santa Monica, CA : Rand Corporation | Perspectives | 2015Marijuana legalization is a controversial and multifaceted issue that is now the subject of serious debate. Since 2012, four U.S. states have passed ballot initiatives to remove prohibition and legalize a for-profit commercial marijuana industry[...]Article : Périodique
The cannabis policy landscape is changing rapidly. In November 2012 voters in Colorado and Washington State passed ballot initiatives to remove the prohibition on the commercial production, distribution, and possession of cannabis. This paper do[...]Article : Périodique
Twenty percent of the U.S. population now lives in states that have passed ballot initiatives to allow cannabis to be sold for recreational use. The net effect of cannabis legalization on public health is uncertain, and much will depend on how t[...]Rapport
B. KILMER ; J. P. CAULKINS ; B. M. BOND ; P. H. REUTER | Santa Monica, CA : Rand Corporation | Occasional Papers | 2010U.S. demand for illicit drugs creates markets for Mexican drug trafficking organizations (DTOs) and helps foster violence in Mexico. This paper examines how marijuana legalization in California might influence DTO revenues and the violence in Me[...]Article : Périodique
Collecting information about the prevalence of cannabis use is necessary but not sufficient for understanding the size, dynamics, and outcomes associated with cannabis markets. This paper uses two data sets describing cannabis consumption in the[...]Article : Périodique
BACKGROUND AND AIMS: Supervised consumption sites (SCS) operate in more than 10 countries. SCS have mostly emerged as a bottom-up response to crises, first to HIV/AIDS and now overdose deaths, in ways that make rigorous evaluation difficult. Opi[...]Article : Périodique
J. P. CAULKINS ; A. TALLAKSEN ; J. TAYLOR ; B. KILMER ; P. REUTER |The 2000-2001 and the 2022-2023 Taliban opium bans were and could be two of the largest ever disruptions to a major illegal drug market. To help understand potential implications of the current ban for Europe, this paper analyzes how opioid mark[...]Article : Périodique
B. PARDO ; J. TAYLOR ; J. CAULKINS ; P. REUTER ; B. KILMER |BACKGROUND: Overdose deaths related to illegal drugs in North American markets are now dominated by potent synthetic opioids such as fentanyl, a circumstance foreshadowed by often-overlooked events in Estonia since the turn of the century. Marke[...]